MiMedx GroupMDXG

那斯達克 · USD
7.19
+0.67
(+10.28%)
收盤 08/01 03:59 (UTC+8)
盤後 
7.21 
+0.02 
(+0.28%)
08/01 03:59 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.72
  • 0.81
  • 0.82
  • 0.87
  • 0.85
  • 0.87
  • 0.84
  • 0.93
  • 0.88
  • 0.99
icon
  • -3.63
  • 13.37
  • 0.56
  • 6.27
  • -2.44
  • 2.95
  • -3.61
  • 10.53
  • -5.06
  • 11.79
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
2023/Q3
2023/Q2
2023/Q1
營業收入淨額
98,605
88,205
92,907
84,057
87,206
84,709
86,832
81,712
81,257
71,676
營業成本
18,68116,55816,90915,32314,85412,98713,84214,79013,58312,419
營業毛利
79,924
71,647
75,998
68,734
72,352
71,722
72,990
66,922
67,674
59,257
營業費用
67,55463,39664,944---57,50067,19867,92462,638
研發費用
3,3033,3283,5712,9183,0112,8412,43311,01211,5096,496
推銷及管理費用
64,15159,96961,04353,51455,40155,12954,35152,57051,95252,279
非經常性項目費用
--137947-9,7013655243,4264,2733,673
其他營業費用
-99193193190189192190190190
營業利益
12,370
8,251
11,054
11,162
23,451
13,198
15,490
-276
-250
-3,381
其他收入及費用
--145-208-21-237-9916-10-342
利息費用
--1,006--1,6906,4574,8641,6311,553
稅前純益
13,007
8,612
11,249
11,419
23,217
11,409
13,913
-1,966
-1,915
-4,932
所得稅
3,3891,5893,8113,5415,5962,348-37,375592-7451
稅後純益
9,618
7,023
7,438
8,095
17,625
9,261
53,477
8,534
1,200
-4,983
基本每股稅後盈餘(元)
0.070.050.050.050.120.06-0.060.00-0.06
稀釋每股稅後盈餘(元)
0.060.050.050.050.120.060.370.060.00-0.06
基本平均股數(千股)
147761.00147272.00147008.00146958.00147326.00146404.00-116298.00115866.00114398.00
稀釋平均股數(千股)
149317.00149677.00149242.00148373.00148897.00150028.00-149773.00146862.00114398.00
還原基本每股稅後盈餘(元)
0.070.050.050.050.120.06-0.060.00-0.06
還原稀釋每股稅後盈餘(元)
0.060.050.050.050.120.060.370.060.00-0.06
還原基本平均股數(千股)
147,761147,272147,008146,958147,326146,404-116,298115,866114,398
還原稀釋平均股數(千股)
149,317149,677149,242148,373148,897150,028-149,773146,862114,398
EBITDA(千元)
16,17511,97415,02613,01024,27914,13723,58715,2763,779-2,332

大家都在看

HOT